{"id":51839,"date":"2022-12-12T12:02:35","date_gmt":"2022-12-12T11:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/"},"modified":"2022-12-12T12:02:35","modified_gmt":"2022-12-12T11:02:35","slug":"epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/","title":{"rendered":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5214907\/epigenetics-market-by-product-by-application-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=32cn89&amp;utm_campaign=1787554+-+Epigenetics+Global+Market+Report+2022%3A+Growing+Applications+in+Non-Oncology+Diseases+Bolster+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global epigenetics market was valued at $1,018.1 million in 2020, and is projected to reach $4,056.86 million by 2030, registering a CAGR of 14.8% from 2021 to 2030.\n<\/p>\n<p>\nThe epigenetics market is expected to grow significantly during the forecast period, owing to rise in incidences of cancer and surge in its application in other chronic diseases such as cardiovascular disorders, metabolic diseases, infectious diseases, and inflammatory diseases. Increase in R&amp;D activities, surge in investments in R&amp;D, growth in epigenetic applications for non-oncology diseases, and increase in partnership between academic, pharmaceutical, and biotechnology companies significantly drive the market growth. However, high cost of instruments and lack of trained professionals impede the market growth.\n<\/p>\n<p>\nFurthermore, untapped potential of emerging markets provides lucrative opportunities to the market players. Moreover, a rise in application of epigenetics processes underlying illness onset and progression has proven critical in recent years for creation of innovative early diagnostic and prognosis biomarkers for assessing patients and its utilization in precision medicine.\n<\/p>\n<p>\n<strong>Key Benefits For Stakeholders<\/strong>\n<\/p>\n<ul>\n<li>\nThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the epigenetics market analysis from 2020 to 2030 to identify the prevailing epigenetics market opportunities.\n<\/li>\n<li>\nThe market research is offered along with information related to key drivers, restraints, and opportunities.\n<\/li>\n<li>\nPorter&#8217;s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.\n<\/li>\n<li>\nIn-depth analysis of the epigenetics market segmentation assists to determine the prevailing market opportunities.\n<\/li>\n<li>\nMajor countries in each region are mapped according to their revenue contribution to the global market.\n<\/li>\n<li>\nMarket player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.\n<\/li>\n<li>\nThe report includes the analysis of the regional as well as global epigenetics market trends, key players, market segments, application areas, and market growth strategies.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Segments<\/strong>\n<\/p>\n<p>\n<strong>By Product<\/strong>\n<\/p>\n<ul>\n<li>\nReagents\n<\/li>\n<li>\nEnzymes\n<\/li>\n<li>\nInstruments\n<\/li>\n<li>\nKits\n<\/li>\n<\/ul>\n<p>\n<strong>By Application<\/strong>\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nNon Oncology\n<\/li>\n<\/ul>\n<p>\n<strong>By End User<\/strong>\n<\/p>\n<ul>\n<li>\nAcademic and Research Institutes\n<\/li>\n<li>\nPharmaceutical and Biotechnology Companies\n<\/li>\n<li>\nContrac Research Organizations\n<\/li>\n<\/ul>\n<p>\n<strong>By Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nU.K.\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest of Asia-Pacific\n<\/li>\n<li>\nLAMEA\n<\/li>\n<li>\nMiddle East And Africa\n<\/li>\n<li>\nLatin America\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Players<\/strong>\n<\/p>\n<ul>\n<li>\nAbcam Plc.\n<\/li>\n<li>\nActive Motif, Inc.\n<\/li>\n<li>\nAgilent Technologies, Inc.\n<\/li>\n<li>\nHologic Inc.\n<\/li>\n<li>\nIllumina Inc.\n<\/li>\n<li>\nMerck Millipore\n<\/li>\n<li>\nPerkinElmer, Inc.\n<\/li>\n<li>\nQIAGEN N.V.\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<li>\nZymo Research\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 1: INTRODUCTION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 2: EXECUTIVE SUMMARY<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 3: MARKET OVERVIEW<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 4: EPIGENETICS MARKET, BY PRODUCT<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 5: EPIGENETICS MARKET, BY APPLICATION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 6: EPIGENETICS MARKET, BY END USER<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 7: EPIGENETICS MARKET, BY REGION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 8: COMPANY LANDSCAPE<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 9: COMPANY PROFILES<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5214907\/epigenetics-market-by-product-by-application-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=32cn89&amp;utm_campaign=1787554+-+Epigenetics+Global+Market+Report+2022%3A+Growing+Applications+in+Non-Oncology+Diseases+Bolster+Sector&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/yvwush<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#58;pr&#x65;&#x73;&#115;&#64;&#x72;&#x65;&#115;&#101;a&#x72;&#x63;&#104;a&#x6e;&#x64;&#109;&#97;r&#x6b;&#x65;&#116;s&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#101;&#115;&#x73;&#x40;&#x72;&#x65;se&#97;&#114;&#x63;&#x68;&#x61;&#x6e;dm&#97;&#114;&#107;&#x65;&#x74;&#x73;&#x2e;co&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global epigenetics market was valued at $1,018.1 million in 2020, and is projected to reach $4,056.86 million by 2030, registering a CAGR of 14.8% from 2021 to 2030. The &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51839","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global epigenetics market was valued at $1,018.1 million in 2020, and is projected to reach $4,056.86 million by 2030, registering a CAGR of 14.8% from 2021 to 2030. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T11:02:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-12T11:02:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/\"},\"wordCount\":529,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005358\\\/en\\\/1661652\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/\",\"name\":\"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005358\\\/en\\\/1661652\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-12T11:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005358\\\/en\\\/1661652\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221212005358\\\/en\\\/1661652\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global epigenetics market was valued at $1,018.1 million in 2020, and is projected to reach $4,056.86 million by 2030, registering a CAGR of 14.8% from 2021 to 2030. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-12T11:02:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector &#8211; ResearchAndMarkets.com","datePublished":"2022-12-12T11:02:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/"},"wordCount":529,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/","name":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg","datePublished":"2022-12-12T11:02:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221212005358\/en\/1661652\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/epigenetics-global-market-report-2022-growing-applications-in-non-oncology-diseases-bolster-sector-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Epigenetics Global Market Report 2022: Growing Applications in Non-Oncology Diseases Bolster Sector &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51839"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51839\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}